News
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...
Shares in pharmaceuticals firm Eli Lilly (LLY) rose today after it said it was suing companies ripping off its weight-loss ...
The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...
18h
Health and Me on MSNNot Just Injections, Weight Loss Drugs Can Be Taken As Daily PillsWeight loss drugs come at a cost, and it is not the MRP you read on the packaging. There are practical complications that ...
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...
Pfizer and Eli Lilly reporting significant - and opposing - news in the GLP-1 industry Lexaria's technology could enhance performance and lower side effects KELOWNA, BC / ACCESS Newswire / April 23, ...
FDA Commissioner Marty Makary talks about his plans to revamp drug development and reduce ‘conflicts of interest’ between the ...
15hOpinion
Montreal Gazette on MSNLabos: Ozempic’s oral counterpart hasn’t caught on yetThe prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...
NEW: Eli Lilly is now suing some bigger-name telehealth companies selling compounded tirzepatide, like Henry Meds and Mochi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results